CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Jeff Collins to serve as a judge for the 2nd Carolina Entrepreneurial Initiative Challenge
News | 04. 22. 2006
